The patient states that she had similar symptoms following her first course of gemcitabine therapy but they resolved on their own.
The patient finished her second cycle of gemcitabine six days prior to admission.
She was then admitted for further management of these symptoms.
Breast cancer, metastatic to liver, bone, diagnosed in [**2125**], status post lumpectomy and XRT with one node positive, therapy finished in [**2126-3-24**].
She was started on Pamidronate at that time.
In [**2132-5-24**], she was given Tamoxifen times nine months and then changed to Arimidex due to an increasing CA27-29.
In [**2134-3-24**], the patient started Taxol and received four cycles until [**2134-6-24**].
In [**2134-8-24**], the patient was started on Fasoodex.
In [**2133-11-24**], the patient was started on gemcitabine for which she is on her second cycle.
Status post cesarean section.
HEMATOLOGY:  The patient was admitted for anemia and transfused 3 units of blood in the ED.
She had inadequate hematocrit increase with this and received an additional 2 units for a total of 5 units of packed red blood cells.
She received seven injections of epinephrine and electrocautery with relief.
METASTATIC BREAST CANCER:  The patient had been treated well with her gemcitabine, on cycle two.
Neurology was consulted and steroids and phenytoin for seizure prophylaxis were started.
Radiation/Oncology also recommended radiation therapy.
Duodenal ulcer, status post electrocautery and epinephrine injection.
Protonix 40 mg p.o.
Dexamethasone 4 mg p.o.
Regular insulin sliding scale while on prednisone.
Lactulose 30 milliliters p.o.
Zofran 2 mg p.o.
Tylenol 650 mg p.o.
Multivitamin one tablet p.o.
Phenytoin 200 mg p.o.
Colace 100 mg p.o.
Dulcolax one tablet p.o.
